Related Experiment Video

Updated: Oct 22, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

134

Pulmonary Vein Stenosis in Children: A Programmatic Approach Employing Primary and Anatomic Therapy

James A Kuo1, Christopher J Petit2

  • 1Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Emory University, Atlanta, GA 30322, USA.

Children (Basel, Switzerland)
|August 27, 2021
PubMed

Insights

Pulmonary vein stenosis (PVS) treatment is challenging. A dedicated PVS Program, combining medical and anatomic therapies, improves patient care and vessel patency.

Area of Science:

  • Cardiology and Interventional Pulmonology

Background:

  • Pulmonary vein stenosis (PVS) presents significant treatment challenges due to high rates of recurrence and disease progression.
  • Effective management requires addressing the complex, multidisciplinary needs of affected patients.

Purpose of the Study:

  • To describe the components and approach of a comprehensive Pulmonary Vein Stenosis (PVS) Program established in 2017.
  • To outline a strategy integrating primary medical therapy with anatomic interventions for PVS management.

Main Methods:

  • Development and implementation of a specialized PVS Program.
  • Application of a combined therapeutic strategy including medical management.
  • Utilization of anatomic interventions aimed at preserving pulmonary vein patency.

Main Results:

  • The program addresses the complex, multidisciplinary requirements of PVS patients.
  • The integrated therapeutic approach aims to maintain vessel patency and manage disease progression.

Conclusions:

  • A multidisciplinary approach is critical for effectively treating patients with pulmonary vein stenosis.
  • Comprehensive PVS Programs offer a structured framework for managing this challenging condition.

Keywords:
congenital heart defectdrug therapypulmonary vein stenosis

More Related Videos

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.2K
Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins06:48

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Published on: October 28, 2020

3.0K

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
54
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
342
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
282
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
88